(IMCD) IMCD - Ratings and Ratios
Adhesives, Pigments, Plasticizers, Solvents, Additives
Description: IMCD IMCD
IMCD N.V. is a global distributor of specialty chemicals and ingredients, operating across multiple regions including Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The companys diverse product portfolio caters to various industries, providing a wide range of chemicals and ingredients that serve as raw materials or additives for manufacturing processes.
From a business perspective, IMCDs strength lies in its ability to offer a broad spectrum of products, making it a one-stop-shop for customers. This is reflected in its revenue streams, which are diversified across different geographies and product categories. Key Performance Indicators (KPIs) to watch for IMCD include revenue growth, gross margin expansion, and operating margin improvement, as these will indicate the companys ability to maintain its market position and capitalize on growth opportunities.
IMCDs financial health can be assessed by examining its return on equity (RoE) of 15.92%, which suggests a relatively strong ability to generate profits from shareholder equity. Additionally, the forward P/E ratio of 16.47 indicates that the market expects earnings growth, potentially driven by the companys operational efficiency and strategic initiatives. Other important KPIs include the companys debt-to-equity ratio, interest coverage ratio, and cash conversion cycle, which can provide insights into its capital structure, financial leverage, and working capital management.
To further evaluate IMCDs investment potential, it is essential to analyze its competitive positioning within the specialty chemicals distribution market. This involves assessing the companys market share, customer relationships, and product offerings relative to its peers. Furthermore, monitoring industry trends, such as the growing demand for sustainable and eco-friendly products, can help identify opportunities and challenges that IMCD may face in the future.
IMCD Stock Overview
| Market Cap in USD | 6,483m |
| Sub-Industry | Trading Companies & Distributors |
| IPO / Inception |
IMCD Stock Ratings
| Growth Rating | -52.1% |
| Fundamental | 62.4% |
| Dividend Rating | 49.0% |
| Return 12m vs S&P 500 | -49.5% |
| Analyst Rating | - |
IMCD Dividends
| Dividend Yield 12m | 1.97% |
| Yield on Cost 5y | 2.50% |
| Annual Growth 5y | 4.47% |
| Payout Consistency | 95.1% |
| Payout Ratio | 30.9% |
IMCD Growth Ratios
| Growth Correlation 3m | -83.1% |
| Growth Correlation 12m | -92.1% |
| Growth Correlation 5y | 12.8% |
| CAGR 5y | -7.99% |
| CAGR/Max DD 3y | -0.18 |
| CAGR/Mean DD 3y | -0.66 |
| Sharpe Ratio 12m | -2.23 |
| Alpha | -52.37 |
| Beta | 0.442 |
| Volatility | 26.69% |
| Current Volume | 201.3k |
| Average Volume 20d | 194.1k |
| Stop Loss | 88.9 (-3%) |
| Signal | -0.25 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (292.3m TTM) > 0 and > 6% of Revenue (6% = 266.6m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -10.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.03% (prev 15.85%; Δ 7.18pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 248.1m <= Net Income 292.3m (YES >=105%, WARN >=100%) |
| Net Debt (1.09b) to EBITDA (545.4m) ratio: 2.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (59.1m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 11.65% (prev 11.97%; Δ -0.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 98.37% (prev 110.8%; Δ -12.39pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.70 (EBITDA TTM 545.4m / Interest Expense TTM 49.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.99
| (A) 0.21 = (Total Current Assets 2.07b - Total Current Liabilities 1.05b) / Total Assets 4.88b |
| (B) 0.19 = Retained Earnings (Balance) 912.7m / Total Assets 4.88b |
| (C) 0.10 = EBIT TTM 431.2m / Avg Total Assets 4.52b |
| (D) 0.34 = Book Value of Equity 912.7m / Total Liabilities 2.66b |
| Total Rating: 2.99 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.39
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 3.37% = 1.69 |
| 3. FCF Margin 5.04% = 1.26 |
| 4. Debt/Equity 0.73 = 2.24 |
| 5. Debt/Ebitda 2.96 = -1.72 |
| 6. ROIC - WACC 4.96% = 6.20 |
| 7. RoE 15.92% = 1.33 |
| 8. Rev. Trend 74.94% = 3.75 |
| 9. Rev. CAGR 22.41% = 2.50 |
| 10. EPS Trend -61.36% = -1.53 |
| 11. EPS CAGR -18.54% = -2.32 |
What is the price of IMCD shares?
Over the past week, the price has changed by -1.25%, over one month by -2.63%, over three months by -23.71% and over the past year by -39.84%.
Is IMCD a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IMCD is around 79.13 EUR . This means that IMCD is currently overvalued and has a potential downside of -13.67%.
Is IMCD a buy, sell or hold?
What are the forecasts/targets for the IMCD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 145.4 | 58.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 86.4 | -5.7% |
IMCD Fundamental Data Overview
Market Cap EUR = 5.54b (5.54b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 522.8m EUR (Cash only, last quarter)
P/E Trailing = 20.1969
P/E Forward = 12.5156
P/S = 1.1447
P/B = 2.7576
Beta = 0.996
Revenue TTM = 4.44b EUR
EBIT TTM = 431.2m EUR
EBITDA TTM = 545.4m EUR
Long Term Debt = 1.32b EUR (from longTermDebt, last quarter)
Short Term Debt = 299.9m EUR (from shortLongTermDebt, last quarter)
Debt = 1.62b EUR (Calculated: Short Term 299.9m + Long Term 1.32b)
Net Debt = 1.09b EUR (from netDebt column, last quarter)
Enterprise Value = 6.63b EUR (5.54b + Debt 1.62b - CCE 522.8m)
Interest Coverage Ratio = 8.70 (Ebit TTM 431.2m / Interest Expense TTM 49.6m)
FCF Yield = 3.37% (FCF TTM 223.8m / Enterprise Value 6.63b)
FCF Margin = 5.04% (FCF TTM 223.8m / Revenue TTM 4.44b)
Net Margin = 6.58% (Net Income TTM 292.3m / Revenue TTM 4.44b)
Gross Margin = 11.65% ((Revenue TTM 4.44b - Cost of Revenue TTM 3.93b) / Revenue TTM)
Tobins Q-Ratio = 7.27 (Enterprise Value 6.63b / Book Value Of Equity 912.7m)
Interest Expense / Debt = 1.81% (Interest Expense 29.3m / Debt 1.62b)
Taxrate = 26.78% (101.8m / 380.0m)
NOPAT = 315.7m (EBIT 431.2m * (1 - 26.78%))
Current Ratio = 1.98 (Total Current Assets 2.07b / Total Current Liabilities 1.05b)
Debt / Equity = 0.73 (Debt 1.62b / last Quarter total Stockholder Equity 2.21b)
Debt / EBITDA = 2.96 (Net Debt 1.09b / EBITDA 545.4m)
Debt / FCF = 7.22 (Debt 1.62b / FCF TTM 223.8m)
Total Stockholder Equity = 1.84b (last 4 quarters mean)
RoA = 5.99% (Net Income 292.3m, Total Assets 4.88b )
RoE = 15.92% (Net Income TTM 292.3m / Total Stockholder Equity 1.84b)
RoCE = 13.68% (Ebit 431.2m / (Equity 1.84b + L.T.Debt 1.32b))
RoIC = 11.17% (NOPAT 315.7m / Invested Capital 2.83b)
WACC = 6.21% (E(5.54b)/V(7.16b) * Re(7.64%)) + (D(1.62b)/V(7.16b) * Rd(1.81%) * (1-Tc(0.27)))
Shares Correlation 3-Years: 60.48 | Cagr: 0.77%
Discount Rate = 7.64% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈383.0m ; Y1≈251.5m ; Y5≈115.0m
Fair Price DCF = 38.29 (DCF Value 2.26b / Shares Outstanding 59.0m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 74.94 | Revenue CAGR: 22.41%
Rev Growth-of-Growth: -56.51
EPS Correlation: -61.36 | EPS CAGR: -18.54%
EPS Growth-of-Growth: 5.69